Statistics

Total Visits

Views
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 197

Total Visits per Month

January 2016 February 2016 March 2016 April 2016 May 2016 June 2016 July 2016
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 0 0 0 4 2 3 1

File Downloads

Views
ijo_34_4_1155_PDF published.pdf 73

Top Country Views

Views
United States 44
Canada 23
Germany 22
Sweden 20
China 17
France 11
United Kingdom 10
Russia 6
South Korea 5
India 2

Top City Views

Views
Miami Beach 17
Nynäs 17
Toronto 13
Beijing 7
Kansas City 5
Zhengzhou 5
Ottawa 4
Dundas 3
Seoul 3
Memphis 2